BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1271 related articles for article (PubMed ID: 18041891)

  • 1. Candida endophthalmitis: focus on current and future antifungal treatment options.
    Khan FA; Slain D; Khakoo RA
    Pharmacotherapy; 2007 Dec; 27(12):1711-21. PubMed ID: 18041891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bilateral endogenous Candida endophthalmitis after induced abortion.
    Sikić J; Vukojević N; Katusić D; Sarić B
    Croat Med J; 2001 Dec; 42(6):676-8. PubMed ID: 11740854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal voriconazole for drug-resistant fungal endophthalmitis: case series.
    Sen P; Gopal L; Sen PR
    Retina; 2006 Oct; 26(8):935-9. PubMed ID: 17031296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of endogenous fungal endophthalmitis: focus on new antifungal agents.
    Riddell J; Comer GM; Kauffman CA
    Clin Infect Dis; 2011 Mar; 52(5):648-53. PubMed ID: 21239843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal lesions as clues to disseminated bacterial and candidal infections: frequency, natural history, and etiology.
    Rodríguez-Adrián LJ; King RT; Tamayo-Derat LG; Miller JW; Garcia CA; Rex JH
    Medicine (Baltimore); 2003 May; 82(3):187-202. PubMed ID: 12792305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of different antifungal treatment regimens for experimental Candida endophthalmitis in rabbit models].
    Koçak N; Kaynak S; Kirdar S; Irmak O; Bahar IH
    Mikrobiyol Bul; 2009 Oct; 43(4):619-26. PubMed ID: 20084915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitrectomy and systemic fluconazole for treatment of endogenous fungal endophthalmitis.
    Christmas NJ; Smiddy WE
    Ophthalmic Surg Lasers; 1996 Dec; 27(12):1012-8. PubMed ID: 8976520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients].
    Cobo Reinoso P; Aguado García JM; Lumbreras Bermejo C; Pérez Vela JL; Caballero Cubedo R; Sanz Sanz F; Noriega Rodríguez AR
    Rev Clin Esp; 1997 Dec; 197(12):799-803. PubMed ID: 9477669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
    Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
    Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.
    Rex JH; Walsh TJ; Sobel JD; Filler SG; Pappas PG; Dismukes WE; Edwards JE
    Clin Infect Dis; 2000 Apr; 30(4):662-78. PubMed ID: 10770728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?
    Charlier C; Hart E; Lefort A; Ribaud P; Dromer F; Denning DW; Lortholary O
    J Antimicrob Chemother; 2006 Mar; 57(3):384-410. PubMed ID: 16449304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal voriconazole for the treatment of endogenous Aspergillus endophthalmitis.
    Kramer M; Kramer MR; Blau H; Bishara J; Axer-Siegel R; Weinberger D
    Ophthalmology; 2006 Jul; 113(7):1184-6. PubMed ID: 16713628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candidemia and invasive candidiasis: a review of the literature for the burns surgeon.
    Ha JF; Italiano CM; Heath CH; Shih S; Rea S; Wood FM
    Burns; 2011 Mar; 37(2):181-95. PubMed ID: 20395056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative endophthalmitis caused by Candida parapsilosis: clinical features and treatment outcomes.
    Scartozzi R; Tom D; Liggett PE; Flynn HW
    Ophthalmic Surg Lasers Imaging; 2011 Mar; 42 Online():e37-9. PubMed ID: 21410086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous Candida endophthalmitis.
    Sallam A; Lynn W; McCluskey P; Lightman S
    Expert Rev Anti Infect Ther; 2006 Aug; 4(4):675-85. PubMed ID: 17009945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-year retrospective review of guideline-based management of fungal endophthalmitis.
    Narendran N; Balasubramaniam B; Johnson E; Dick A; Mayer E
    Acta Ophthalmol; 2008 Aug; 86(5):525-32. PubMed ID: 18752527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular manifestations of candidemia.
    Oude Lashof AM; Rothova A; Sobel JD; Ruhnke M; Pappas PG; Viscoli C; Schlamm HT; Oborska IT; Rex JH; Kullberg BJ
    Clin Infect Dis; 2011 Aug; 53(3):262-8. PubMed ID: 21765074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presumed Candida endogenous fungal endophthalmitis: a case report and literature review.
    Najmi NG; Song HF; Ober RR
    Optometry; 2007 Sep; 78(9):454-9. PubMed ID: 17765856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment outcomes in a 10-year study of endogenous fungal endophthalmitis.
    Essman TF; Flynn HW; Smiddy WE; Brod RD; Murray TG; Davis JL; Rubsamen PE
    Ophthalmic Surg Lasers; 1997 Mar; 28(3):185-94. PubMed ID: 9076791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fluconazole era: management of hematogenously disseminated candidiasis in the nonneutropenic patient.
    Kramer KM; Skaar DJ; Ackerman BH
    Pharmacotherapy; 1997; 17(3):538-48. PubMed ID: 9165556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.